跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLIAN 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SOLIAN 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
SOLIAN 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi Aventis
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 29, 2020
Approval ID
21906e212c5e55f6
Company
Sanofi Aventis
Type
Standard
Approval Details
Approval Id
21906e212c5e55f6
Drug Cima Aemps Name
SOLIAN 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
5267-21102009
Holder Company Name
Sanofi Aventis
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/sanofi-aventis-france
Authorization Date
2020-05-29
Dosage Form
COMPRIMIDO RECUBIERTO
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi Aventis
Company Detail Path
/organization/sanofi-aventis-france
Company Information
Pharmaceutical Company Name
SANOFI-AVENTIS FRANCE
Country Name
France
City Name
noumea,territoires d'outre-mer,country_fr
Address
Motor-Pool
Active Ingredients
AMISULPRIDA
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 29, 2020
Approval ID
21906e212c5e55f6
Type
Standard
Back to CIMA-AEMPS Approvals
